DNA X Inc
SONM
8 hedge funds and large institutions have $284K invested in DNA X Inc in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.01% less ownership
Funds ownership: 0.12% → 0.1% (-0.01%)
2% less capital invested
Capital invested by funds: $291K → $284K (-$7.23K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$896 |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$358 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$119 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
First Foundation Advisors
Irvine,
California
|
-$33.7K |
| 2 |
Barclays
London,
United Kingdom
|
-$26 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $159K | – | – | – |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $65.7K | +$358 | +6 | +0.5% |
|
3
Dimensional Fund Advisors
Austin,
Texas
| $50.9K | – | – | – |
|
4
Citigroup
New York
| $4.61K | – | – | – |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $2.06K | +$2.15K | +36 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $864 | +$896 | +15 | New |
|
|
7
Bank of America
Charlotte,
North Carolina
| $196 | +$119 | +2 | +200% |
|
8
BNP Paribas Financial Markets
Paris,
France
| $66 | – | – | – |
|
9
JP Morgan Chase
New York
| $19 | – | – | – |
|
|
DB
10
Danske Bank
Copenhagen K,
Denmark
| $3 | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $3 | – | – | – |
|
|
FFA
12
First Foundation Advisors
Irvine,
California
| – | -$33.7K | -647 | Closed |
|
|
13
Barclays
London,
United Kingdom
| – | -$26 | -1 | Closed |
|
SONM Hedge Fund Activity: Q4 2024 in Review
8 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q4 2024, worth a combined $284K — down 2.5% from $291K a quarter earlier.
Fund positioning in SONM was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $896. The largest seller was First Foundation Advisors, exiting entirely with an estimated $33.7K sold.
- 8 institutional investors held DNA X Inc (SONM) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $284K of DNA X Inc stock for Q4 2024, down 2.5% quarter-over-quarter.
- 2 funds opened new DNA X Inc positions in Q4 2024 and 2 closed out, a net change of 0 holders.
- The largest DNA X Inc buyer in Q4 2024 was Tower Research Capital (TRC), an estimated $896 added.
- The largest DNA X Inc seller in Q4 2024 was First Foundation Advisors, an estimated $33.7K sold.
Based on aggregated 13F filings for Q4 2024.